The global Vitamin K3 Market demonstrated substantial strength in 2021 and is projected to exhibit a rapid revenue compound annual growth rate (CAGR) throughout the forecast period. The growth of market revenue is primarily attributed to the increasing utilization of vitamin K3 in various applications such as commercial pet diets for dogs and cats, poultry and pig feed additives, and cancer research.

Vitamin K3, also known as menadione, is an artificial and synthetic form of vitamin K. It is a white or off-white crystalline powder that tends to cake when exposed to moisture. This dietary supplement is commonly used in animal foods. In animal feed, vitamin K3 is utilized because of its ability to convert to its active form, facilitate proper blood clotting, and contribute to natural bone calcification. However, it is not used in humans due to its adverse effects on human health. In the past, vitamin K3 was administered to children to prevent vitamin K deficiency.

Get a free sample PDF of the report, visit @ https://www.reportsanddata.com/download-free-sample/5878

However, its use was discontinued due to the development of kernicterus, a severe brain damage condition resulting from ingestion, which causes limited mobility, loss of appetite, convulsions, deafness, mental retardation, and even death. Additionally, vitamin K3 in injectable form is employed to synthesize prothrombin and other proteins involved in blood coagulation. It also aids in the conversion of prothrombin to thrombin, another protein essential for the production of blood clots to stop bleeding.

Furthermore, the medical field utilizes vitamin K3 because it is necessary for the creation of a urine protein that plays a role in kidney function, preventing the formation of calcium oxalate kidney stones. Moreover, the increasing applications of vitamin K3 as a food additive in the pet and animal food industry, as well as its potential efficacy in cancer cell treatment, are driving the growth of market revenue.

Several factors contribute to the revenue growth of the global vitamin K3 market. The growing demand for the product as animal supplements in pet food and farm feed can be attributed to its ability to synthesize vitamin K-dependent plasma proteins involved in the blood clotting process. It provides an adequate amount required by the liver and supports the production of other proteins needed for metabolism. Additionally, it plays a significant role in coprophagy, facilitating the thorough absorption of microbially produced vitamins K. Furthermore, its form allows for direct utilization by the liver and easy transformation into the metabolically active form of vitamin K, making it efficient for synthesis in the animal body. These factors drive the demand and market growth during the forecast period.

However, certain factors restrain the revenue growth of the global vitamin K3 market. The increasing health consequences associated with the use of the product in humans hinder its usage, leading to reduced demand. Common adverse effects include pain, swelling, temporary flushing, taste changes, dizziness, rapid pulse, sweating, shortness of breath, difficulty in breathing, enlarged liver, and discoloration of lips, skin, and nails. Consequently, its usage as an artificial supplement in humans is limited. Moreover, the U.S. Food and Drug Administration has banned menadione supplements for humans due to their high toxicity and severe health consequences. These health hazards associated with the use of vitamin K3 in humans impede its application, thereby restraining revenue growth in the market.

Despite the challenges, there are opportunities for players in the global vitamin K3 market. The increasing research on the use of the product for cancer treatment, leveraging its anti-cancer and anti-inflammatory properties, presents growth opportunities. Vitamin K3 has been found to enhance the creation of reactive oxygen species, molecules that can harm or kill cancer cells. Consequently, it is being used in various cancer research procedures. Ongoing studies indicate that vitamins C and K3 work together to prevent the development and growth of human breast and prostate cancer cells. Research exploring the potential of this compound as a cancer treatment component opens up avenues for market growth.

The global vitamin K3 market revenue growth is driven by the product segment. The Menadione Sodium Bisulphite (MSB) segment is expected to register significant revenue growth during the forecast period, primarily due to its benefits in animal feed. This product is extensively used in animal food as it aids in blood clotting and coagulation. Furthermore, it serves as a coenzyme in other metabolic processes such as bone mineralization, protein production, and cell development, contributing to overall animal development and driving product demand. The menadione sodium bisulfite complex is readily absorbed compared to other alternatives, making it a preferred choice. Additionally, it is utilized in the production of various clotting factors and anticoagulant proteins, ensuring effective prothrombin production. The mentioned uses of this product are expected to drive demand and revenue growth in the market.

To know more about the latest insights of the report, visit @ https://www.reportsanddata.com/request-latest-insight/5878

In terms of application, the feed additives segment is projected to experience significant revenue growth over the forecast period. This is attributed to the substantial utilization of vitamin K3 in feed additives due to its coagulating properties. It can undergo prenylation in animals and is metabolized in the liver to become a crucial cofactor in the activation of Gla proteins. These proteins play a vital role in blood clotting, bone function, and artery function. Furthermore, MSB is added to drinking water to enhance chromium exposure in domesticated animals, leading to improved lifespans, reproduction, and a reduced prevalence of metabolic problems, stress impacts, and illness. Studies highlighting the beneficial effects of this commodity are expected to further increase demand and drive revenue growth.

In terms of regional analysis, the North American region is anticipated to account for the largest revenue share in the global vitamin K3 market. This growth can be attributed to the increasing number of pets owned in the region. The product is commonly used as an additive in pet and animal food, which boosts its demand. According to data from the North American Pet Health Insurance Association, pet ownership increased by 67% from 2019 to 2021-22, contributing to the rise in product demand. Additionally, the presence of over 2,500 slaughterhouses in the U.S. in 2019, as reported by Sentientmedia, further increases the demand for vitamin K3 and drives market growth in the region.

The European region is expected to lead in terms of revenue CAGR. This is attributed to the increasing cancer rates in the region. According to data from the World Cancer Research Fund International, over 80% of countries in Europe reported the highest age-standardized cancer rate. This prevalence of cancer will drive research and development (R&D) efforts to explore the use of vitamin K3 as a potential cancer treatment, increasing its demand in the market. Numerous studies have demonstrated the anti-carcinogenic and antibacterial properties of vitamin K3. For instance, a study published in the International Journal of Molecular Sciences in March 2019 showed inhibited expression of cancer cells when using vitamin K3. These findings contribute to market growth in the European region.

Major companies in the market include Shandong Huasheng Chemical Technology Co., Ltd., Brother Enterprises, Haining Peace Chemical Co., Ltd., Oxyvit Kimya, Dirox SA, Mianyang Vanetta Chemical Industrial Co., Ltd., Hubei Zhenhua Chemical Co., Ltd., Peace Chemical Industry Co., Ltd., Chongqing Minfeng Chemical Co., Ltd., and Vishal Laboratories. The strategies and objectives of these major companies were not available at the time of writing.

In conclusion, the global vitamin K3 market is poised for significant growth, driven by factors such as increased usage in pet diets, animal feed additives, and research for cancer treatments. However, the market faces challenges related to health consequences in humans and restrictions on its use in human supplements. Opportunities lie in further research on the compound's potential as a cancer treatment. The product segment, particularly Menadione Sodium Bisulphite (MSB), and the feed additives application segment are expected to contribute significantly to revenue growth. The North American region is projected to dominate the market, while Europe is expected to lead in terms of revenue CAGR. Overall, the global vitamin K3 market presents promising prospects for players in the industry.

Request a customized copy of the report @

https://www.reportsanddata.com/request-customization-form/5878

Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.  

Browse for more reports:

https://www.reportsanddata.com/report-detail/endoscopic-operative-devices-market

https://www.reportsanddata.com/report-detail/genome-editing-market

https://www.reportsanddata.com/report-detail/3d-imaging-market

https://www.reportsanddata.com/report-detail/disposable-gloves-market

https://www.reportsanddata.com/report-detail/global-biosimilars-market

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact:

John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
LinkedIn | Twitter | Blogs